Decision Regret Uncommon After Radical Prostatectomy, IMRT

This article originally appeared here.
Share this content:
Decision Regret Uncommon After Radical Prostatectomy, IMRT
Decision Regret Uncommon After Radical Prostatectomy, IMRT

MONDAY, Aug. 22, 2016 (HealthDay News) -- For patients with prostate cancer treated with radical prostatectomy (RP) and post-prostatectomy image-guided intensity-modulated radiotherapy (IG-IMRT), decision regret (DR) is uncommon and occurs more often after RP, according to research published online Aug. 16 in the Journal of Medical Imaging and Radiation Oncology.

Thomas P. Shakespeare, M.B.B.S., from the Mid North Coast Cancer Institute in Coffs Harbour, Australia, and colleagues surveyed 83 patients treated with RP and IG-IMRT with minimum follow-up of five years. A validated questionnaire was used to determine whether men had DR about treatment.

The researchers found that the median follow-up was 78 months post-IMRT. In 28, 72, and 48 percent of patients, adjuvant IG-IMRT, salvage, and androgen deprivation therapy (ADT) were used, respectively. Seventy percent of patients remained disease-free. A total of 16.9 percent of patients expressed DR for treatment; compared to radiotherapy, there was more regret for the RP component of treatment (16.9 versus 4.2 percent; P = 0.01). For androgen deprivation, DR was 14.3 percent. Regrets for surgery were due to toxicity, not being adequately informed about alternatives such as radiotherapy, positive margins, and costs of surgery (83, 33, 25, and 8 percent, respectively). In the three radiotherapy-regretful and four ADT-regretful patients, toxicity caused DR. For salvage versus adjuvant approaches, patients were twice as regretful overall and of surgery (both 19.6 versus 10.0 percent).

"Decision regret after RP and post-prostatectomy IG-IMRT is uncommon, although patients regret RP more than postoperative IG-IMRT," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Alzheimer's Mortality Up 55 Percent From 1999 to 2014

CDC: Alzheimer's Mortality Up 55 Percent From 1999 ...

More patients also dying at home, with the caregiving burden often falling on loved ones

Targeting ANGPTL3 Can Significantly Lower Cholesterol

Targeting <i>ANGPTL3</i> Can Significantly Lower Cholesterol

Two trials show promise for non-statin approach to cardiovascular disease prevention

Factors Raise Risk of Pregnancy-Related Stroke in Preeclampsia

Factors Raise Risk of Pregnancy-Related Stroke in Preeclampsia

Infections, clotting disorders, chronic hypertension all found to increase risk

is free, fast, and customized just for you!

Already a member?

Sign In Now »